Amgen Inc. - Net Worth and Insider Trading
Amgen Inc. Net Worth
The estimated net worth of Amgen Inc. is at least $22.9 Billion dollars as of 2024-06-17. Amgen Inc. is the 2101 Beneficial owner of BeiGene Ltd and owns about 236,249,845 shares of BeiGene Ltd (HKSE:06160) stock worth over $22.9 Billion. Details can be seen in Amgen Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amgen Inc. has not made any transactions after 2020-07-17 and currently still holds the listed stock(s).
Transaction Summary of Amgen Inc.
Amgen Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amgen Inc. owns 1 companies in total, including BeiGene Ltd (HKSE:06160) .
Click here to see the complete history of Amgen Inc.’s form 4 insider trades.
Insider Ownership Summary of Amgen Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06160 | BeiGene Ltd | 2020-07-17 | 2101 Beneficial owner |
Amgen Inc. Latest Holdings Summary
Amgen Inc. currently owns a total of 1 stock. Amgen Inc. owns 236,249,845 shares of BeiGene Ltd (HKSE:06160) as of July 17, 2020, with a value of $22.9 Billion.
Latest Holdings of Amgen Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06160 | BeiGene Ltd | 2020-07-17 | 236,249,845 | 97.05 | 22,928,047,457 |
Holding Weightings of Amgen Inc.
Amgen Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Amgen Inc. has made a total of 1 transactions in BeiGene Ltd (HKSE:06160) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in BeiGene Ltd is the sale of 0 shares on July 17, 2020, which brought Amgen Inc. around $0.
Insider Trading History of Amgen Inc.
- 1
Amgen Inc. Trading Performance
Amgen Inc. Ownership Network
Amgen Inc. Owned Company Details
What does BeiGene Ltd do?
Who are the key executives at BeiGene Ltd?
Amgen Inc. is the 2101 Beneficial owner of BeiGene Ltd. Other key executives at BeiGene Ltd include 2101 Beneficial owner Oyler John Victor , 2502 Approved lending agent JPMorgan Chase & Co. , and 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. .
BeiGene Ltd (HKSE:06160) Insider Trades Summary
Over the past 18 months, Amgen Inc. made no insider transaction in BeiGene Ltd (HKSE:06160). Other recent insider transactions involving BeiGene Ltd (HKSE:06160) include a net purchase of 14,449,821 shares made by JPMorgan Chase & Co. , a net sale of 559,949 shares made by Oyler John Victor , and a net purchase of 2,302,280 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 220,701 shares of BeiGene Ltd (HKSE:06160) in total and bought 0 shares, with a net sale of 220,701 shares. During the past 18 months, 59,036,556 shares of BeiGene Ltd (HKSE:06160) were sold and 19,216,128 shares were bought by its insiders, resulting in a net sale of 39,820,428 shares.
BeiGene Ltd (HKSE:06160)'s detailed insider trading history can be found in Insider Trading Tracker table.
BeiGene Ltd Insider Transactions
Amgen Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Amgen Inc.. Currently GuruFocus does not have mailing address information for Amgen Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
